John J. Rossi

Dean, Graduate School of Biological Sciences at Beckman Research Institute of the City of Hope

John J. Rossi

John J. Rossi

Dean, Graduate School of Biological Sciences at Beckman Research Institute of the City of Hope

Overview
Career Highlights

Dicerna Pharmaceuticals, Inc.

RelSci Relationships

1297

Number of Boards

7

Birthday

1947

Age

72

Relationships
RelSci Relationships are individuals John J. Rossi likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chairman, Department of Diabetes & Metabolic Disease Research at Beckman Research Institute of the City of Hope

Relationship likelihood: Strong

Co-Founder at CS-Keys, Inc.

Relationship likelihood: Strong

Chief, Neurosurgery & Director, Brain Tumor Program at City of Hope - California

Relationship likelihood: Strong

Mediator at United States Bankruptcy Court for the Central District of California

Relationship likelihood: Strong

Former Chief Executive Officer at Beckman Research Institute of the City of Hope

Relationship likelihood: Strong

Assistant Secretary & Chief Operating Officer at City of Hope - California

Relationship likelihood: Strong

Board Member at City of Hope - California

Relationship likelihood: Strong

Director at City of Hope - California

Relationship likelihood: Strong

Former President at Valley Forge Life Insurance Co.

Relationship likelihood: Strong

Vice Provost & Associate Director at Beckman Research Institute of the City of Hope

Relationship likelihood: Strong

Paths to John J. Rossi
Potential Connections via
Relationship Science
You
John J. Rossi
Dean, Graduate School of Biological Sciences at Beckman Research Institute of the City of Hope
Education
Ph.D., Microbial Genetics

The University of Connecticut (UConn) is a public research university in Connecticut. Known as a Public Ivy,[3] UConn was founded in 1881 and is a Land Grant and Sea Grant college & member of the Space Grant Consortium. The institution serves more than 30,000 students on its six campuses, including more than 8,000 graduate students in multiple programs.[4] UConn's main campus is in Storrs, Connecticut. The university's president is Susan Herbst.[5] UConn is one of the founding institutions of the Hartford, Connecticut/Springfield, Massachusetts regional economic and cultural partnership alliance known as New England's Knowledge Corridor. UConn is a member of Universitas 21, a global network of 24 research-intensive universities, who work together to foster global citizenship and institutional innovation through research-inspired teaching and learning, student mobility, connecting students and staff, and promote advocacy for internationalisation.[6] UConn is accredited by the New England Association of Schools and Colleges.

B.A., Biology

UNH is a vibrant place: a land-, sea-, and space-grant university located in Durham, N.H., Concord, N.H. and Manchester, NH.

Postdoc, Biology & Medicine

Brown University is located in historic Providence, Rhode Island and was founded in 1764. It is the seventh-oldest college in the United States. Brown is an independent, coeducational Ivy League institution comprising undergraduate and graduate programs, plus the Alpert Medical School, School of Public Health, School of Engineering, and the School of Professional Studies.

Career History
Adjunct Professor, Department of Biochemistry & Microbiology
Current

EDUCATING ETHICAL AND PROFICIENT CHRISTIAN HEALTH PROFESSIONALS AND SCHOLARS THROUGH INSTRUCTION, EXAMPLE, AND THE PURSUIT OF TRUTH;EXPANDING KNOWLEDGE THROUGH RESEARCH IN THE BIOLOGICAL, BEHAVIORAL, PHYSICAL, AND ENVIRONMENTAL SCIENCES AND APPLYING THIS KNOWLEDGE TO HEALTH AND DISEASE; PROVIDING COMPREHENSIVE, COMPETENT, AND COMPASSIONATE HEALTH CARE FOR THE WHOLE PERSON THROUGH FACULTY, STUDENTS, AND ALUMNI.

Dean, Graduate School of Biological Sciences
Current

TO QUICKLY TURN RESEARCH IDEAS INTO NEW TREATMENTS AND CURES THROUGH MEDICAL AND BIOMEDICAL RESEARCH AND DISEASE INVESTIGATION, INCLUDING DNA SYNTHESIS AND CELL ANALYSIS.

Collaborator, Gene Therapy Research
2016 - Current

American Gene Technologies International, Inc. operates as a gene and cell therapeutics company. It provides treatments for infectious diseases, cancers and monogenic disorders. The company was founded by Jeffrey A. Galvin in 2007 and is headquartered in Rockville, MD.

Boards & Committees
Chairman, Scientific Advisory Board
Current

Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of treatments for rare diseases, chronic liver diseases, cardiovascular disease, and viral liver infectious diseases. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson and John J. Rossi in 2007 and is headquartered in Watertown, MA.

Member, Scientific Advisory Board
Current

American Gene Technologies International, Inc. operates as a gene and cell therapeutics company. It provides treatments for infectious diseases, cancers and monogenic disorders. The company was founded by Jeffrey A. Galvin in 2007 and is headquartered in Rockville, MD.

Member, Scientific Advisory Board
Current

Silenseed Ltd. operates as a biopharmaceutical company. Its programs include SiG12D-LODER for pancreatic cancer, and Prostate-LODER, GBM-LODER for brain cancer. The company was founded by Dr. Amotz Shemi and Prof. Eithan Galun on November 30, 2008 and is headquartered in Modi'in, Israel.

Associate Chair of the Shared Resources Advisory Committee, Comprehensive Cancer Center
2001 - Current

City of Hope National Medical Center, commonly City of Hope, is a private, not-for-profit clinical research center, hospital and graduate medical school located in Duarte, California, United States. The center's main campus resides on 110-acre (45 ha) of land adjacent to the boundaries of Duarte and Irwindale, with satellite offices in Monrovia and downtown Los Angeles, and regional fundraising offices throughout the country.

Member, Board of Directors
Tenure Unconfirmed

TO QUICKLY TURN RESEARCH IDEAS INTO NEW TREATMENTS AND CURES THROUGH MEDICAL AND BIOMEDICAL RESEARCH AND DISEASE INVESTIGATION, INCLUDING DNA SYNTHESIS AND CELL ANALYSIS.

Investments
Details Hidden

Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of treatments for rare diseases, chronic liver diseases, cardiovascular disease, and viral liver infectious diseases using its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James C. Jenson and John J. Rossi in 2007 and is headquartered in Watertown, MA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by John J. Rossi. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of John J. Rossi's profile does not indicate a business or promotional relationship of any kind between RelSci and John J. Rossi.